RA CAPITAL MANAGEMENT L.P. 13D and 13G filings for Mineralys Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-09-08 6:00 pm Purchase | 2025-09-04 | 13D | Mineralys Therapeutics, Inc. MLYS | RA CAPITAL MANAGEMENT L.P. | 7,796,433 9.900% | 1,508,836 (+24.00%) | Filing |
| 2025-03-17 7:58 pm Purchase | 2025-03-13 | 13D | Mineralys Therapeutics, Inc. MLYS | RA CAPITAL MANAGEMENT L.P. | 6,287,597 9.900% | 1,338,290 (+27.04%) | Filing |
| 2024-02-12 4:49 pm Purchase | 2024-02-12 | 13D | Mineralys Therapeutics, Inc. MLYS | RA CAPITAL MANAGEMENT L.P. | 4,949,307 9.990% | 4,949,307 (New Position) | Filing |